Results 131 to 140 of about 37,577 (242)

Effect of Ambient Temperature on Intradialytic Hypotension in Hemodialysis Patients: A Retrospective Cohort Study. [PDF]

Kidney Med
He Y, Qian Y, Xu Q, Sheng X, Zhang N.
europepmc   +1 more source

Real‐World Validation of the Clinical Distinctiveness of IDH‐Mutant Glioblastoma in the SEER Transition Era: A Population‐Based Study Integrating Machine Learning

Brain and Behavior, Volume 16, Issue 8, August 2026.
ABSTRACT Introduction The 2021 WHO classification reclassified “IDH‐mutant glioblastoma (GBM)” as “Astrocytoma, IDH‐mutant, grade 4.” This study aims to provide real‐world validation of this reclassification using the specific ICD‐O‐3 code (9445/3) from the Surveillance, Epidemiology, and End Results (SEER) “Transition Era” (2018–2022) and develop a ...
Dewei Du, Amu Jike, Dongnan Yu, Shizheng Tan, Shuming Wang, Shun Li   +5 more
wiley   +1 more source

Association of CDKN2A/B and MTAP deletions in adult-type diffuse gliomas. [PDF]

J Neuropathol Exp Neurol
Ebner BA, Ida CM, Kollmeyer TM, Jenkins RB, Zepeda Mendoza CJ, Giannini C, Trejo-Lopez JA, Raghunathan A.   +7 more
europepmc   +1 more source

Microbiota–Neuroinflammation Crosstalk in Primary Brain Tumors: Focus on Glioblastoma

Brain and Behavior, Volume 16, Issue 8, August 2026.
Microbiota–neuroinflammation crosstalk in GBM. The schematic summarizes how gut microbiota and microbiota‐derived signals may influence GBM biology through gut–brain signaling, microbial metabolites, systemic immune modulation, BBB‐related pathways, tumor‐associated microbial signals, and immune‐metabolic changes within the GBM microenvironment.
Tareq Nayef AlRamadneh, Renuka Jyothi S, Priya Priyadarshini Nayak, Anima Nanda, Shaker Al Hasnaawei, Akanksha Bhatt, Ashish Singh Chauhan, Siya Singla, Mehrdad Nourizadeh   +8 more
wiley   +1 more source

Diastolic Morning Surge Improves Risk Stratification for Subclinical Left Ventricular Diastolic Dysfunction in Ambulatory-Defined Isolated Diastolic Hypertension. [PDF]

J Clin Hypertens (Greenwich)
Cosgun A, Oren H.
europepmc   +1 more source

Deep Learning‐Based Multimodal Fusion of Whole‐Slide Images and RNA Sequencing Identifies Survival‐Relevant Glioblastoma Clusters

Cancer Medicine, Volume 15, Issue 8, August 2026.
ABSTRACT Glioblastoma is profoundly heterogeneous, and single‐modality analyses often miss prognostically relevant structure. We introduce a transparent, end‐to‐end workflow that fuses available whole‐slide histology and RNA‐seq to discover clinically meaningful glioblastoma subgroups using an unsupervised learning model after feature extraction ...
Amin Zadeh Shirazi, Guillermo A. Gomez
wiley   +1 more source

Mass Spectrometry in Chiral Analysis and Synthesis

Chirality, Volume 38, Issue 8, August 2026.
Chiral molecules have the same mass, yet there are MS approaches that can distinguish chiral molecules. MS‐based chiral chemistry matters in fundamental physical experiments, industrial applications, and clinical analysis. ABSTRACT Mass spectrometry (MS) has a role to play in chiral chemistry, in part through methods based on microdroplets and non ...
Brison A. Shira, Mahdiyeh Shahi, R. Graham Cooks   +2 more
wiley   +1 more source

DNA copy number patterns reveal prognostic markers and elucidate mechanisms of evolution in IDH-mutant astrocytoma. [PDF]

Neuro Oncol
Drucker KL, Panda A, Decker PA, Kosel ML, Kollmeyer TM, Burns TC, Maqbool MA, Shafqat S, Suvakov M, Zadeh G, Giannini C, Vaubel R, Raghunathan A, Parney IF, Kizilbash SH, Ida CM, Abyzov A, Lachance DH, Eckel-Passow JE, Jenkins RB.   +19 more
europepmc   +1 more source

Harnessing Repurposed Drugs to Enhance Temozolomide Efficacy in Glioblastoma

Cancer Reports, Volume 9, Issue 8, August 2026.
ABSTRACT Background Glioblastoma (GB) is the most aggressive primary malignant brain tumor in adults and remains associated with poor survival despite surgical resection followed by radiotherapy and temozolomide (TMZ) chemotherapy. Intrinsic and acquired resistance to TMZ, including MGMT‐dependent DNA repair and activation of pro‐survival pathways ...
Ali Nakhaei, Atefeh Taghavi, Amir R. Afshari, Farzaneh Davoudi, Elaheh Gheybi, Mohammad Jalili‐Nik   +5 more
wiley   +1 more source

Current and emerging therapies in IDH-mutant glioma. [PDF]

Neurotherapeutics
Nakhate V, Youssef G, Wen PY.
europepmc   +1 more source